Evidence map›Paper›PMID 31097161›Full record

ArticleJournal of the American College of Cardiology2019

Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease.

Joo Myung Lee, Ki Hong Choi, Bon-Kwon Koo, Jonghanne Park, Jihoon Kim, Doyeon Hwang, Tae-Min Rhee, Hyung Yoon Kim, Hae Won Jung, Kyung-Jin Kim and 14 more

3 registry-linked trialsOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of the American College of Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 95 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 3 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06863545 narecruitingstarted 2025, after this paper: background citation

Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography

Ran2025Enrolled3,596Registered outcomes11Posted comparisons0ConditionsCardiovascular Events, Coronary Artery Disease, CT Angiography, PCSK9ArmsPCSK9 inhibitors and background lipid-modifying therapy, Standard lipid-modifying therapy
Open the trial in the graph
NCT01621438 unknown statusnot on this map

Influence of Total Atherosclerotic Burden Assessed by 3-vessel Fractional Flow Reserve (FFR) on the Clinical Outcomes of the Patients With Multi-vessel Disease

TypeobservationalSponsorSeoul National University HospitalRan2012 to 2018Enrolled1,136ConditionsMultivessel Coronary Artery Disease
NCT04547231 unknown statusnot on this mapstarted 2020, after this paper: background citation

Impact of Stenosis and Plaque Features in Coronary CT Angiography, Physiologic Assessment and Pharmacotherapy on the Clinical Outcomes After Invasive Coronary Angiography

TypeobservationalSponsorSeoul National University HospitalRan2020 to 2025Enrolled992ConditionsCoronary Artery DiseaseArmsFractional flow reserve, Coronary CT angiography
3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 3 syntheses or guidelines pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Impact of Complete Revascularization in the ISCHEMIA Trial.Journal of the American College of Cardiology · 2023
    Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Functional or anatomical assessment of non-culprit lesions in acute myocardial infarction.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 4 countries.

Joo Myung LeeDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ki Hong ChoiDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Bon-Kwon KooDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea; Institute on Aging, Seoul National University, Seoul, Korea. Electronic address: bkkoo@snu.ac.kr.
Jonghanne ParkDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Jihoon KimDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Doyeon HwangDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Tae-Min RheeDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Hyung Yoon KimDepartment of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
Hae Won JungDepartment of Cardiology, Daegu Catholic University Medical Center, Daegu, Korea.
Kyung-Jin KimDepartment of Internal Medicine, Ewha Womans University Medical Center, Ewha Womans University School of Medicine, Seoul, Korea.
Kawase YoshiakiDepartment of Cardiology, Gifu Heart Center, Gifu, Japan.
Eun-Seok ShinDepartment of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea; Division of Cardiology, Ulsan Hospital, Ulsan, Korea.
Joon-Hyung DohDepartment of Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
Hyuk-Jae ChangDivision of Cardiology, Severance Cardiovascular Hospital, Yonsei-Cedars-Sinai Integrative Cardiovascular Imaging Research Center, Yonsei University College of Medicine, Seoul, Korea.
Yun-Kyeong ChoDepartment of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
Hyuck-Jun YoonDepartment of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
Chang-Wook NamDepartment of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
Seung-Ho HurDepartment of Medicine, Keimyung University Dongsan Medical Center, Daegu, Korea.
Jianan WangDepartment of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Shaoliang ChenDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Shoichi KuramitsuDepartment of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
Nobuhiro TanakaDepartment of Cardiology, Tokyo Medical University, Tokyo, Japan.
Hitoshi MatsuoDepartment of Cardiology, Gifu Heart Center, Gifu, Japan.
Takashi AkasakaWakayama Medical University, Wakayama, Japan.
Keimyung University Dongsan Medical Center · KRSamsung Medical Center · KRSeoul National University Hospital · KRGifu Heart Center · JPChonnam National University Hospital · KRDaegu Catholic University Medical Center · KREwha Womans University Medical Center · KRInje University Ilsan Paik Hospital · KRKokura Memorial Hospital · JPNanjing Medical University · CNSecond Affiliated Hospital of Zhejiang University · CNSeoul National University · KRTokyo Medical University · JPUlsan College · KRWakayama Medical University · JPYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the presence of ischemia is a key prognostic factor in patients with coronary artery disease, the presence of high-risk plaque characteristics (HRPC) is also associated with increased risk of cardiovascular events. Limited data exist regarding the prognostic implications of combined information on physiological stenosis severity assessed by fractional flow reserve (FFR) and plaque vulnerability by coronary computed tomography angiography (CTA)-defined HRPC.

objectivesThe current study aimed to evaluate the: 1) association between physiological stenosis severity and coronary CTA-defined HRPC; and 2) prognostic implications of coronary CTA-defined HRPC according to physiological stenosis severity in patients with coronary artery disease.

methodsA total of 772 vessels (299 patients) evaluated by both coronary CTA and FFR were analyzed. The presence and number of HRPC (minimum lumen area <4 mm

resultsThe proportion of lesions with ≥3 HRPC was significantly decreased according to the increase in FFR values (58.6%, 46.5%, 36.8%, 15.7%, and 3.5% for FFR ≤0.60, 0.61 to ≤0.70, 0.71 to ≤0.80, 0.81 to ≤0.90, and >0.90, respectively; overall p value <0.001). Both FFR and number of HRPC showed significant association with the estimated risk of VOCO (p = 0.008 and p = 0.023, respectively). In the FFR >0.80 group, lesions with ≥3 HRPC showed significantly higher risk of VOCO than those with <3 HRPC (15.0% vs. 4.3%; hazard ratio: 3.964; 95% confidence interval: 1.451 to 10.828; p = 0.007). However, there was no significant difference in the risk of VOCO according to HRPC in the FFR ≤0.80 group. By multivariable analysis, the presence of ≥3 HRPC was independently associated with the risk of VOCO in the FFR >0.80 group.

conclusionsPhysiological stenosis severity and the number of HRPC were closely related, and both components had significant association with the risk of clinical events. However, the prognostic implication of HRPC was different according to FFR. Integration of both physiological stenosis severity and plaque vulnerability would provide better prognostic stratification of patients than either individual component alone, especially in patients with FFR >0.80. (Clinical Implication of 3-vessel Fractional Flow Reserve [3V FFR-FRIENDS study]; NCT01621438).

Indexed as

AgedComputed Tomography AngiographyConstriction, PathologicCoronary AngiographyCoronary Artery DiseaseCoronary StenosisCoronary VesselsFemaleFractional Flow Reserve, MyocardialHumansMaleMiddle AgedPlaque, AtheroscleroticPrognosisRisk AssessmentRisk Factorscoronary artery diseasecoronary CT angiographyfractional flow reserveischemiaprognosis

Identifiers

PMID31097161
OpenAlexW2946677191

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.